APA
Click to copy
Steenblock, C., Walther, R., Tselmin, S., Jarzebska, N., Voit-Bak, K., Toepfner, N., … Rodionov, R. (2022). Long Covid and Apheresis - Where are we Standing? Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme.
Chicago/Turabian
Click to copy
Steenblock, C., R. Walther, S. Tselmin, N. Jarzebska, K. Voit-Bak, N. Toepfner, T. Siepmann, et al. “Long Covid and Apheresis - Where Are We Standing?” Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme (2022).
MLA
Click to copy
Steenblock, C., et al. “Long Covid and Apheresis - Where Are We Standing?” Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme, 2022.
BibTeX Click to copy
@article{c2022a,
title = {Long Covid and Apheresis - Where are we Standing?},
year = {2022},
journal = {Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme},
author = {Steenblock, C. and Walther, R. and Tselmin, S. and Jarzebska, N. and Voit-Bak, K. and Toepfner, N. and Siepmann, T. and Passauer, J. and Hugo, C. and Wintermann, G. and Julius, U. and Barbir, M. and Khan, T. and Puhan, M. and Straube, R. and Hohenstein, B. and Bornstein, S. and Rodionov, R.}
}
A continual increase in cases of Long Covid constitutes a medical and socioeconomic challenge to health systems around the globe. While the true extent of this problem cannot yet be fully evaluated, recent data suggests that up to 20% of people with confirmed with SARS-CoV-2 suffer from clinically relevant symptoms of Long Covid several weeks to months after the acute phase. The clinical presentation is highly variable with the main symptoms being chronic fatigue, dyspnea and cognitive symptoms. Extracorporeal apheresis has been suggested to alleviate symptoms of Long Covid. Thus, numerous patients are currently treated with apheresis. However, at present there is no data from randomized controlled trials available to confirm the efficacy. Therefore, physicians rely on the experience of practitioners and centers performing this treatment. Here, we summarize clinical experience on extracorporeal apheresis in patients with Long Covid from centers across Germany.